92 related articles for article (PubMed ID: 9555007)
21. In vitro antiaggregation and deaggregation potential of Rhizophora mucronata and its bioactive compound (+)- catechin against Alzheimer's beta amyloid peptide (25-35).
Suganthy N; Sheeja Malar D; Pandima Devi K
Neurol Res; 2016 Dec; 38(12):1041-1051. PubMed ID: 27766923
[TBL] [Abstract][Full Text] [Related]
22. Ca(2+), within the physiological concentrations, selectively accelerates Abeta42 fibril formation and not Abeta40 in vitro.
Ahmad A; Muzaffar M; Ingram VM
Biochim Biophys Acta; 2009 Oct; 1794(10):1537-48. PubMed ID: 19595795
[TBL] [Abstract][Full Text] [Related]
23. In silico investigation on the inhibition of Aβ
Dutta M; Mattaparthi VSK
J Biomol Struct Dyn; 2018 Feb; 36(3):741-752. PubMed ID: 28278027
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous in vitro formation of supramolecular beta-amyloid structures, "betaamy balls", by beta-amyloid 1-40 peptide.
Westlind-Danielsson A; Arnerup G
Biochemistry; 2001 Dec; 40(49):14736-43. PubMed ID: 11732892
[TBL] [Abstract][Full Text] [Related]
25. An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease.
Habchi J; Arosio P; Perni M; Costa AR; Yagi-Utsumi M; Joshi P; Chia S; Cohen SI; Müller MB; Linse S; Nollen EA; Dobson CM; Knowles TP; Vendruscolo M
Sci Adv; 2016 Feb; 2(2):e1501244. PubMed ID: 26933687
[TBL] [Abstract][Full Text] [Related]
26. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils.
Cui L; Zhang Y; Cao H; Wang Y; Teng T; Ma G; Li Y; Li K; Zhang Y
J Alzheimers Dis; 2013; 37(1):19-28. PubMed ID: 23727899
[TBL] [Abstract][Full Text] [Related]
27. The relationship between Abeta-associated free radical generation and Abeta fibril formation revealed by negative stain electron microscopy and thioflavine-T fluorometric assay.
Monji A; Utsumi H; Yoshida I; Hashioka S; Tashiro K; Tashiro N
Neurosci Lett; 2001 May; 304(1-2):65-8. PubMed ID: 11335056
[TBL] [Abstract][Full Text] [Related]
28. Effects of novel acylhydrazones derived from 4-quinolone on the acetylcholinesterase activity and Aβ42 peptide fibrils formation.
da Silva GS; Figueiró M; Tormena CF; Coelho F; Almeida WP
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1464-70. PubMed ID: 26928712
[TBL] [Abstract][Full Text] [Related]
29. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
Gu L; Tran J; Jiang L; Guo Z
J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
[TBL] [Abstract][Full Text] [Related]
30. Catechol derivatives inhibit the fibril formation of amyloid-beta peptides.
Huong VT; Shimanouchi T; Shimauchi N; Yagi H; Umakoshi H; Goto Y; Kuboi R
J Biosci Bioeng; 2010 Jun; 109(6):629-34. PubMed ID: 20471605
[TBL] [Abstract][Full Text] [Related]
31. The membrane-active amphibian peptide caerin 1.8 inhibits fibril formation of amyloid β1-42.
Liu Y; Wang T; Calabrese AN; Carver JA; Cummins SF; Bowie JH
Peptides; 2015 Nov; 73():1-6. PubMed ID: 26275335
[TBL] [Abstract][Full Text] [Related]
32. The Multimerization State of the Amyloid-β42 Amyloid Peptide Governs its Interaction Network with the Extracellular Matrix.
Salza R; Lethias C; Ricard-Blum S
J Alzheimers Dis; 2017; 56(3):991-1005. PubMed ID: 28106549
[TBL] [Abstract][Full Text] [Related]
33. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators.
Tõugu V; Karafin A; Zovo K; Chung RS; Howells C; West AK; Palumaa P
J Neurochem; 2009 Sep; 110(6):1784-95. PubMed ID: 19619132
[TBL] [Abstract][Full Text] [Related]
34. Menadione sodium bisulfite inhibits the toxic aggregation of amyloid-β(1-42).
Zhang Y; Zhao Y; Wang Z; Gong H; Ma L; Sun D; Yang C; Li Y; Cheng B; Petersen RB; Jiang F; Liu G; Huang K
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2226-2235. PubMed ID: 30036601
[TBL] [Abstract][Full Text] [Related]
35. Conserved S/T Residues of the Human Chaperone DNAJB6 Are Required for Effective Inhibition of Aβ42 Amyloid Fibril Formation.
Månsson C; van Cruchten RTP; Weininger U; Yang X; Cukalevski R; Arosio P; Dobson CM; Knowles T; Akke M; Linse S; Emanuelsson C
Biochemistry; 2018 Aug; 57(32):4891-4902. PubMed ID: 30024736
[TBL] [Abstract][Full Text] [Related]
36. Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro.
Hao J; Zhang W; Zhang P; Liu R; Liu L; Lei G; Su C; Miao J; Li Z
Neuropeptides; 2010 Aug; 44(4):305-13. PubMed ID: 20363024
[TBL] [Abstract][Full Text] [Related]
37. Systems Pharmacology Analysis of the Amyloid Cascade after β-Secretase Inhibition Enables the Identification of an Aβ42 Oligomer Pool.
van Maanen EM; van Steeg TJ; Michener MS; Savage MJ; Kennedy ME; Kleijn HJ; Stone JA; Danhof M
J Pharmacol Exp Ther; 2016 Apr; 357(1):205-16. PubMed ID: 26826190
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of A beta fibril formation and A beta-induced cytotoxicity by senile plaque-associated proteins.
Monji A; Yoshida I; Tashiro K; Hayashi Y; Matsuda K; Tashiro N
Neurosci Lett; 2000 Jan; 278(1-2):81-4. PubMed ID: 10643806
[TBL] [Abstract][Full Text] [Related]
39. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation.
Poduslo JF; Howell KG
J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128
[TBL] [Abstract][Full Text] [Related]
40. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH
PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
